1,371 results on '"CORTESE, Bernardo"'
Search Results
2. Drug-Coated Balloon in Acute Coronary Syndromes: Ready for the Prime Time?
3. Predictors and Long-Term Prognostic Significance of Bailout Stenting During Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the Eastbourne Study
4. Coronary drug-coated balloons: A comprehensive review of clinical applications and controversies
5. Is the axiom of balloon angioplasty, “the more you gain the more you lose,” still true in the era of DCB with paclitaxel?
6. Sirolimus-coated balloon versus drug-eluting stent for complex coronary lesions. A propensity matched comparison
7. Sirolimus-coated balloon in acute and chronic coronary syndromes: the PEACE study, a subanalysis of the EASTBOURNE registry
8. Balón liberador de sirolimus en el tratamiento del síndrome coronario agudo y crónico: el estudio PEACE, un subanálisis del registro EASTBOURNE
9. Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study
10. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry
11. Clinical outcomes of a dedicated bifurcation stent system
12. Five-year clinical outcomes of STEMI patients treated with a pre-specified bioresorbable vascular scaffold implantation technique: Final results of the BVS STEMI STRATEGY-IT
13. Safety and efficacy of single antiplatelet therapy in a large cohort of patients treated with sirolimus-coated balloon: Post hoc analysis from the prospective EASTBOURNE registry
14. Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: A subanalysis of the EASTBOURNE study
15. Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
16. A Clinical Appraisal of Optical Coherence Tomography for Left Main Stem Intervention
17. Is There a Role for OCT for Left Main Assessment Before and After PCI?
18. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels
19. Design and rationale of a prospective, randomized, non-inferiority trial to determine the safety and efficacy of the Biolimus A9™ drug coated balloon for the treatment of in-stent restenosis: First-in-man trial (REFORM)
20. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score
21. Comparison of Outcomes Between 1- and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions
22. Validation of a Contemporary Acute Kidney Injury Risk Score in Patients With Acute Coronary Syndrome
23. Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry
24. Coronary Lithotripsy as Elective or Bail-Out Strategy After Rotational Atherectomy in the Rota-Shock Registry
25. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up
26. Utilization of Non–Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States
27. Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
28. Small Vessel Coronary Artery Disease: Rationale for Standardized Definition and Critical Appraisal of the Literature
29. Drug-coated balloon coronary angioplasty: where are we going?
30. Differential Prognosis of True Bifurcation Lesions According to Left Main Versus Non-Left Main Location and Treatment Strategy.
31. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)
32. Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)
33. ImpaCt of an Optimal Implantation Strategy on Absorb Long-Term Outcomes: The CIAO Registry
34. Comparison Between Sirolimus- and Paclitaxel-Coated Balloon for Revascularization of Coronary Arteries: The SIRPAC (SIRolimus-PAClitaxel) Study
35. Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry
36. A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial
37. Previous Mistakes with DCB Technology, and How to Prevent Them in the Future
38. The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis
39. Cost/Effectiveness and Reimbursement Policies with Drug-Coated Balloons in Europe
40. History of Drug-Coated Balloons
41. Drug-Coated Balloons for Native Femoro-popliteal Disease
42. Dissection Management with Drug-Coated Balloons
43. Sirolimus-Coated Balloon: Insights on a New Technology for Coronary Use
44. Drug-Coated Balloons in Native Coronary Artery Disease
45. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
46. Drug‐coated balloons in high‐risk patients and diabetes mellitus: A meta‐analysis of 10 studies.
47. Temporal Trends in Mortality Related to Stroke and Atrial Fibrillation in the United States: A 21‐Year Retrospective Analysis of CDC‐WONDER Database.
48. Paclitaxel-Coated Versus Sirolimus-Coated Eluting Balloons for Percutaneous Coronary Interventions: Pharmacodynamic Properties, Clinical Evidence, and Future Perspectives.
49. Long‐term outcomes of DCB and DES for the treatment of in‐stent restenosis in relation to the vessel size.
50. Long-term benefits of drug-coated balloons for coronary artery revascularization.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.